UHS Stock Surges 11% In 5-Day Spree On Dividend And Analyst Buy Ratings
Universal Health Services (UHS) – a provider of acute care hospitals and behavioral health facilities. – hit a 5-day winning streak, with cumulative gains over this period amounting to 11%. The company’s market cap has surged by about $1.4 Bil over the last 5 days and currently stands at $15 Bil.
The stock has YTD (year-to-date) return of 7.9% compared to 0.5% for S&P 500. This calls for a re-evaluation of the stock’s valuation to find out whether this is an opportunity or a trap.
What Triggered The Rally?
[1] Dividend Declaration and Sustained Institutional Accumulation
- Dividend of $0.20/share announced on Feb 12, 2026
- Zacks Rank #2 (Buy) with an A grade for Value on Feb 16, 2026
- Impact: Strengthened Investor Confidence, Increased Buying Pressure
Opportunity or Trap?
Below is our take on valuation.
There is a near-equal mix of good and bad in UHS stock given its overall Moderate operating performance and financial condition. Hence, despite its Low valuation, this makes the stock look Risky (For details, see Buy or Sell UHS).
But here is the real interesting point.
You are reading about this 11% move after it happened. The market has already priced in the news. To catch the next winner before the headlines, you need predictive signals, not notifications. Our High Quality Portfolio has flagged 5 new opportunities that have not surged yet.
Returns vs S&P 500
The following table summarizes the return for UHS stock vs. the S&P 500 index over different periods, including the current streak:
| Return Period | UHS | S&P 500 |
|---|---|---|
| 1D | 0.1% | 0.6% |
| 5D (Current Streak) | 10.6% | -0.9% |
| 1M (21D) | 17.7% | -0.8% |
| 3M (63D) | 4.6% | 2.2% |
| YTD 2026 | 7.9% | 0.5% |
| 2025 | 22.0% | 16.4% |
| 2024 | 18.2% | 23.3% |
| 2023 | 8.8% | 24.2% |
However, big gains can follow sharp reversals – but how has UHS behaved after prior drops? See UHS Dip Buyer Analysis to learn more.
Gains and Losses Streaks: S&P 500 Constituents
There are currently 99 S&P constituents with 3 days or more of consecutive gains and 17 constituents with 3 days or more of consecutive losses.
| Consecutive Days | # of Gainers | # of Losers |
|---|---|---|
| 3D | 82 | 10 |
| 4D | 11 | 5 |
| 5D | 3 | 2 |
| 6D | 1 | 0 |
| 7D or more | 2 | 0 |
| Total >=3 D | 99 | 17 |
Key Financials for Universal Health Services (UHS)
Last 2 Fiscal Years:
| Metric | FY2023 | FY2024 |
|---|---|---|
| Revenues | $14.3 Bil | $15.8 Bil |
| Operating Income | $1.2 Bil | $1.7 Bil |
| Net Income | $717.8 Mil | $1.1 Bil |
Last 2 Fiscal Quarters:
| Metric | 2025 FQ2 | 2025 FQ3 |
|---|---|---|
| Revenues | $4.3 Bil | $4.5 Bil |
| Operating Income | $500.3 Mil | $521.7 Mil |
| Net Income | $353.2 Mil | $373.0 Mil |
While UHS stock looks attractive given its winning streak, investing in a single stock without detailed, thorough analysis can be risky. The Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 — the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.